Switzerland-based manufacturer of flavours, fragrances and active cosmetic ingredients Givaudan has made new strategic investments in skin microbiome research.

The company has made investments in its Applied Microbiomics Centre of Excellence in Toulouse, France, as part of continued contributions towards its active beauty business unit and its metagenomics platform.

Givaudan Active Beauty head Laurent Bourdeau said: “Not only are these investments in line with our 2020 company strategy, but our astonishing advancements in microbiomics allow us to bring ground-breaking cosmetic concepts to new and existing customers.”

Givaudan Fragrance Division president Maurizio Volpi said: “It’s incredibly fascinating for a fragrance house to lead the creation of new active cosmetic ingredients in microbiomics.

“Our astonishing advancements in microbiomics allow us to bring ground-breaking cosmetic concepts to new and existing customers.”

“I’m very proud of the team in our Applied Microbiomics Centre of Excellence, which is constantly pioneering the ingredients of tomorrow.”

Givaudan’s active beauty division is involved in developing active cosmetic ingredients, designed to activate, protect and balance the skin’s microbiota. As part of the company’s Fragrance division, it offers a range of active cosmetic ingredients for anti-ageing, self-tanning, soothing, hydrating and cooling.

Research on the skin microbiome carried out by Givaudan’s scientists led to the creation of microbiome-activated ingredients and microbiome-protecting agents, which in turn resulted in the development of active cosmetic ingredients Brightenyl and Revivyl.